Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Sally Sansom

Sally Sansom

Sally Sansom

DPhil Student

Sally is a DPhil in Population Health candidate within the Health Economics Research Centre (HERC), under the supervision of Professor Sarah Wordsworth, Dr James Buchanan, Dr Padraig Dixon, and Associate Professor Michele Peters.

Sally is passionate about progressing the health economics evidence base required to support the cost-effective translation of genomic diagnostic and therapeutic technologies into routine care. Through her DPhil, Sally is exploring the valuation of outcomes associated with genome sequencing in economic evaluations. In particular, Sally is seeking to determine which patient- and caregiver-reported instruments are best suited to measuring the outcomes from genome sequencing for rare disease diagnosis in the context of health economic evaluations. Sally is grateful to have been awarded a full scholarship in support of her studies funded by the Clarendon Fund, Mary Somerville Scholarship and a Department of Population Health Studentship. 

Sally is also a Junior Research Fellow within the Centre for Personalised Medicine (CPM) at the University of Oxford, as well as a Coordinator of the Econ-Omics Special Interest Group within the International Health Economics Association (IHEA), and a member of the Data Access Committee for the Global Angelman Syndrome Registry.

Prior to commencing her DPhil, Sally worked for eight years in roles spanning health economics and strategy consulting, and medical research / clinical trial project management. Sally also holds a Bachelor of Biomedicine (genetics major) from the University of Melbourne, and a Master of Public Health (health economics specialism) from Monash University in Australia.